Nemanja Djokovic
Nemanja Djokovic
Faculty of Pharmacy, University of Belgrade
Adresse e-mail validée de
Citée par
Citée par
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Z Gagic, D Ruzic, N Djokovic, T Djikic, K Nikolic
Frontiers in Chemistry 7, 873, 2020
Modulating protein–protein interactions with visible‐light‐responsive peptide backbone photoswitches
L Albert, A Peñalver, N Djokovic, L Werel, M Hoffarth, D Ruzic, J Xu, ...
ChemBioChem 20 (11), 1417-1429, 2019
The oxidoreductase PYROXD1 uses NAD (P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response
I Asanović, E Strandback, A Kroupova, D Pasajlic, A Meinhart, ...
Molecular Cell 81 (12), 2520-2532. e16, 2021
Structure-based design of selective histone deacetylase 6 zinc binding groups
LA Alves Avelar, D Ruzic, N Djokovic, T Kurz, K Nikolic
Journal of Biomolecular Structure and Dynamics 38 (11), 3166-3177, 2020
Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands
M Elek, N Djokovic, A Frank, S Oljacic, A Zivkovic, K Nikolic, H Stark
Archiv der Pharmazie 354 (6), 2000486, 2021
Fragment-based drug design of selective HDAC6 inhibitors
D Ruzic, N Djokovic, K Nikolic
Protein-Ligand Interactions and Drug Design, 155-170, 2021
Bistable Photoswitch allows in vivo control of hematopoiesis
L Albert, J Nagpal, W Steinchen, L Zhang, L Werel, N Djokovic, D Ruzic, ...
ACS central science 8 (1), 57-66, 2021
An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease
N Djokovic, D Ruzic, T Djikic, S Cvijic, J Ignjatovic, S Ibric, K Baralic, ...
Molecular Informatics 40 (5), 2000187, 2021
Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein
C Bon, Y Si, M Pernak, M Barbachowska, E Levi-Acobas, V Cadet Daniel, ...
Molecules 26 (17), 5300, 2021
Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics
N Djokovic, D Ruzic, M Rahnasto-Rilla, T Srdic-Rajic, ...
Journal of Chemical Information and Modeling 62 (10), 2571-2585, 2022
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
D Ruzic, B Ellinger, N Djokovic, JF Santibanez, S Gul, M Beljkas, A Djuric, ...
Pharmaceutics 14 (12), 2600, 2022
Medicinal chemistry of histone deacetylase inhibitors
D Ružić, N Đoković, K Nikolić, Z Vujić
Arhiv za farmaciju 71 (2), 73-100, 2021
Reversible Control of RNA Splicing by Photoswitchable Small Molecules
L Zhang, X Xie, N Djokovic, K Nikolic, D Kosenkov, F Abendroth, ...
Journal of the American Chemical Society, 2023
Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma
N Djokovic, A Djuric, D Ruzic, T Srdic-Rajic, K Nikolic
Pharmaceuticals 16 (2), 294, 2023
SIRT2i_Predictor: A machine learning-based tool to facilitate the discovery of novel SIRT2 inhibitors
N Djokovic, M Rahnasto-Rilla, N Lougiakis, M Lahtela-Kakkonen, ...
Pharmaceuticals 16 (1), 127, 2023
Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors
D Ružić, N Đoković, T Srdić-Rajić, K Nikolić
Serbian Chemical Society and Serbian Young Chemists’ Club, Book of Abstracts, 15, 2022
Discovery of 1-benzhydryl piperazine-based HDAC inhibitors with anti-cancer and anti-metastatic properties against human breast cancer: synthesis, molecular modeling, in vitro …
D Ruzic, M Petkovic, N Djokovic, J Santibanez, B Ellinger, M Beljkas, ...
Computer-aided drug design and evaluation of selective inhibitors against cytoplasmic histone deacetylases
D Ružić, N Đoković, M Petković, S Gul, M Lahtela‐Kakkonen, A Ganesan, ...
37th ACS National Medicinal Chemistry Symposium-American Chemical Society …, 2022
Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies
C Bon, M Barbachowska, N Djokovic, D Ruzic, Y Si, L Soresinetti, C Jallet, ...
Future Medicinal Chemistry 14 (8), 557-570, 2022
Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6
D Ružić, N Đoković, M Petković, S Gul, M Lahtela‐Kakkonen, A Ganesan, ...
EFMC-ISMC, XXVII EFMC International Symposium on Medicinal Chemistry, Book …, 2022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20